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Background:  Endomyocardial biopsies and magnetic resonance imaging studies have suggested that myocardial inflammation might play a part 
in the development of stress-induced cardiomyopathy (SCM). Studies also showed elevated levels of high-sensitivity C-reactive protein (hs-CRP) is 
related to the impairment of left ventricular function and B-type natriuretic peptide (BNP) release in SCM. We hypothesized that elevated levels of 
hs-CRP as an inflammatory marker would have a prognostic value in patients with SCM presenting as shock and death.
Methods:  We prospectively recruited 73 consecutive patients with SCM. Hs-CRP was measured at initial presentation by an immunoturbidimetric 
assay. The primary endpoint was a major adverse clinical event (MACE; defined as the combination of any death and cardiogenic shock) and two 
groups were divided and compared with each other according to MACE.
Results:  MACE was identified in 23 patients (32%). In baseline demographics, MACE group was relatively young (56.4±19.1 vs. 69.2±11.9 years, 
p=0.006) and showed advanced NYHA class (68 vs. 24%, p=0.003) with elevated creatinine (7.1±8.2 vs. 2.9±3.8 mg/dL, p=0.027) and lower low-
density lipoprotein (73.3±32.9 vs. 97.7±43.8, p=0.039). The MACE group showed significantly higher median levels of hs-CRP at hospital admission 
(35.8, inter-quartile range (IQR) 15.2-92.5 vs. 11.5, IQR 2.0-39.7 mg/L, p=0.013) and decreased initial left ventricular ejection fraction (LVEF) 
(36.9±14.7 vs. 47.4±11.4%, p=0.001). By multivariate logistic regression analysis, elevated levels of hs-CRP and reduced LVEF (per 5% decrement) 
were independent predictors of MACE (OR: 4.948, 95% confidence interval (CI): 1.413-17.327, OR: 3.229, 95% CI: 1.296-8.048, respectively). The 
patients with higher levels of hs-CRP and decreased LVEF were significantly associated with occurrence of MACE (p<0.001).
Conclusions:  Hs-CRP as well as LVEF at hospital admission shows an additional predictive value of MACE in patients with SCM. The present study 
suggests that systemic inflammation may be crucial for the pathogenesis and prognosis of SCM.
